Humacyte (HUMA)
NASDAQ:HUMA
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 2.04M | $ 0.00 | $ 0.00 | $ 1.56M | $ 1.26M |
| Gross Profit | $ -15.01M | $ -7.19M | $ -76.55M | $ -6.69M | $ -60.08M |
| Operating Income | $ -107.44M | $ -114.40M | $ -100.05M | $ -84.58M | $ -81.21M |
| EBITDA | $ -100.09M | $ -132.23M | $ -96.46M | $ -76.37M | $ -72.97M |
| Net Income | $ -40.83M | $ -148.70M | $ -110.78M | $ -11.96M | $ -26.48M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 50.50M | $ 44.94M | $ 80.45M | $ 151.88M | $ 225.50M |
| Total Assets | $ 116.37M | $ 137.87M | $ 128.22M | $ 204.30M | $ 286.53M |
| Total Debt | $ 64.85M | $ 16.54M | $ 57.45M | $ 50.07M | $ 51.18M |
| Net Debt | $ 14.35M | $ -28.40M | $ -23.00M | $ -99.71M | $ -166.32M |
| Total Liabilities | $ 113.26M | $ 190.54M | $ 114.68M | $ 87.37M | $ 164.36M |
| Stockholders' Equity | $ 3.11M | $ -52.67M | $ 13.55M | $ 116.93M | $ 122.17M |
| Cash Flow | |||||
| Free Cash Flow | $ -105.93M | $ -99.69M | $ -75.58M | $ -72.18M | $ -81.41M |
| Operating Cash Flow | $ -105.04M | $ -98.12M | $ -73.31M | $ -71.13M | $ -81.19M |
| Investing Cash Flow | $ -884.00K | $ -1.57M | $ -173.00K | $ 4.84M | $ -8.22M |
| Financing Cash Flow | $ 61.49M | $ 114.18M | $ 4.51M | $ -1.45M | $ 266.98M |